Transcatheter mitral valve replacement

نویسندگان

چکیده

Transcatheter mitral valve (MV) repair, specifically the edge-to-edge leaflet is a less invasive treatment of symptomatic regurgitation (MR) in patients with high or prohibitive surgical risk. In cases severe calcification, small orifice area, and/or extremely wide across entire MV commissure, transcatheter repair may rather cause suboptimal potentially hazardous outcomes. these cases, replacement can be more suitable option. Recently, percutaneous has emerged as an acceptable therapeutic option for degenerated bioprosthetic disease. Moreover, several devices native are under evaluation hope to provide complete and reproducible restoration function. this article, we will review current status, applications, clinical outcomes, limitations that need overcome both disease disorders.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

متن کامل

Transcatheter mitral valve replacement: A frontier in cardiac intervention.

As transcatheter aortic valve replacement (TAVR) has become routine, device manufacturers and investigational cardiologists have set their sights on the mitral valve. Although transcatheter mitral valve replacement (TMVR) poses several technical challenges, they appear to be surmountable, and work is proceeding. Here we review the various devices being developed and preliminary results of trial...

متن کامل

Transcatheter Mitral Valve Replacement With a Novel Dual Stent Bioprosthesis.

There has been great interest in transcatheter mitral valve replacement (TMVR) as a potential therapy for high-risk patients with severe mitral regurgitation, with several distinct device systems undergoing first-in-man clinical studies. The Intrepid TMVR (Medtronic Inc, Redwood City, CA), designed for transapical delivery, comprises 2 interconnected self-expanding nitinol stents: (1) an inner ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Cardiology

سال: 2021

ISSN: ['1876-4738', '0914-5087']

DOI: https://doi.org/10.1016/j.jjcc.2020.10.020